Industrial Commodities and Biotechs Stand Out Among Micro Cap Stocks for 2016

DELRAY BEACH, FL / ACCESSWIRE / December 16, 2015 / Investors and day traders alike seeking high potential returns may want to take a glance at companies vying to stay competitive in today’s market through integrated revenue strategies and vital international placement. One up-and-coming, potentially groundbreaking company in area of industrial commodities distribution is CD International Enterprises (CDII), a micro cap industrial commodities company that seeks to establish an impressive industry presence through trading deals and consulting ventures.

In turning away from more traditional cash-flow industries common in the mineral and mining business, the key strategy that has lead to CDII’s recent string of success has been a greater focus on business management by engaging in consultation-based projects and judicious acquisitions. The corporation’s recent partnership with APM Terminal, one of the world’s largest port owners, has afforded CDII greater opportunity to facilitate construction projects across South America and Africa. Further, CD International’s acquisition of China-based holding company HK International Finance & Investment Group Limited granted them the advantageous addition of diversified business operations in the construction design, hospitality, and health endowment industries. Since globalized small cap stocks tend to anticipate exponential growth, CDII’s game plan has potential for a sudden, impressive increase in market share.

This recent paradigm shift has resulted in new revenue streams previously unseen during the corporation’s stint in legacy manufacturing, but CD International stands to reap major rewards from its global network in the minerals and mining industry. At the beginning of December, the company’s wholly owned subsidiary, Capital Resources Management Corporation, acquired a substantial purchase order for 240K tons of copper concentrate. Through its vast networks and legacy manufacturing presence in the Chinese market, as well as its strategic business representation in South America, this extraordinary requisition is expected to pay out $350 million dollars over the next 24 months. Upon the announcement of this transaction, CD International saw a drastic increase of nearly 5,000% in share value in just one day, immediately resulting greater market mobility as well as opportunity for savvy investors able to capitalize on the timing of their transactions.

In the biotech arena, Ekso Bionic Holdings, Inc. (EKSO) has also moved to enact strategic acquisitions. Currently trading at 1.13 and boasting a market cap of 115M, the biotech go-getter recently acquired proprietary gravity-balancing arm technology from Equipois, LLC. As per their seller/reseller agreement, Equipois will continue to sell gravity-balancing arm products such as zeroG(TM) and X-Ar(TM), and Ekso will expand gravity-balancing exoskeleton technology for the purposes of human augmentation across the health and labor sectors.

Another active player utilizing mergers and acquisitions for competing market share is Legacy Ventures International, Inc. (LGYV), whose recent acquisition of RM Fresh Brands, Inc. garnered a lucrative business deal between the subsidiary and Toronto-based Sysco, a leader in supplying food products and equipment to a variety of food-service establishments.

Trading at 3.78, the innovative green-tech company SolarWindow Technologies, Inc. (WNDW) also seeks to provide environmental relief through clean energy practices. At the forefront of the company’s business strategy lies their proprietary window-glass that converts sunlight to electricity. In a statement released by John A. Conklin, CEO, SolarWindow potentially seeks to soon formulate industry relationships to increase growth potential: “Commercial buildings alone consume nearly 40% of the electricity generated in the U.S. This is one reason why we’ve targeted commercial buildings as our initial customers… In 2016, our mission is to formalize industry relationships, potentially giving us instant commercial reach.”

While global markets fluctuate, it may be worthwhile for investors to turn to micro and small cap stocks as a viable alternative to augment their portfolios. The above selections stand out in a crowd, with CD International’s recent successes speaking volumes about that company’s future potential.

Seraphim Strategies is a third party publisher. Not a registered broker/dealer/analyst/adviser, holds no investment licenses and may not sell, offer to sell or offer to buy any security. Market updates, news alerts and corporate profiles are not a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is not to be interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. For full disclaimer please read http://tomorrowsbluechips.com/disclaimer/ This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

“Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may,” “future,” “plan” or “planned,” “will” or “should,” “expected,” “anticipates,” “draft,” “eventually,” or “projected.” You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements.

SOURCE: Seraphim Strategies LLC

ReleaseID: 434792